Chinese bioethicists call for ‘reboot’ of regulations following CRISPR babies

Four bioethics professors from prominent Chinese universities proposed steps that could "reboot" research ethics in China including top-down regulation and increased bioethics training.

The need for ethical reforms for China's clinical trial system was highlighted in November when Jiankui He announced he had used CRISPR-based gene editing to create HIV-resistant embryos that led to the birth of two gene-edited babies (see "China’s Germline Growing Pain").

In a commentary in Nature, Ruiping Lei of Huazhong University of Science and

Read the full 762 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE